BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1252669)

  • 1. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
    Park HS; Hourani SM
    Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex.
    Xie B; Tang W; Wen S; Chen F; Yang C; Wang M; Yang Y; Liang W
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly oxidized low-density lipoprotein does not facilitate platelet aggregation.
    Miyazaki A; Uehara T; Usami Y; Ishimine N; Sugano M; Tozuka M
    J Int Med Res; 2020 Oct; 48(10):300060520958960. PubMed ID: 33100088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro study on the effect of fibrinogen γ-chain peptide-coated ADP-encapsulated liposomes on postcardiopulmonary bypass coagulopathy using patient blood.
    Ishida O; Hagisawa K; Yamanaka N; Nakashima H; Kearney BM; Tsutsumi K; Takeoka S; Kinoshita M
    J Thromb Haemost; 2023 Jul; 21(7):1934-1942. PubMed ID: 36990156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro Research of the Concentration Dependence of Effect of Adrenaline on Platelets Aggregation.
    Mati E; Piperea-Sianu A; Sarbu I; Croitoru A; Borisova S
    Curr Health Sci J; 2017; 43(1):41-46. PubMed ID: 30595853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Cordycepin-Enriched WIB801C from Cordyceps militaris Suppressing Fibrinogen Binding to Glycoprotein IIb/IIIa.
    Lee DH; Kim HH; Lim DH; Kim JL; Park HJ
    Biomol Ther (Seoul); 2015 Jan; 23(1):60-70. PubMed ID: 25593645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
    Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
    J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in aggregation by and uptake of 5-hydroxytryptamine with platelets from rabbits treated with chlorpromazine.
    Baldacci M; Baldacci M; Bergel TD; Born GV; Hickman M
    Br J Pharmacol; 1980 May; 69(1):113-8. PubMed ID: 7378650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanisms of the potentiation of blood-platelet activation by adrenaline.
    Bushfield M; McNicol A; MacIntyre DE
    Biochem J; 1987 Feb; 241(3):671-6. PubMed ID: 3593215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?
    Graf M; Pletscher A
    Br J Pharmacol; 1979 Apr; 65(4):601-8. PubMed ID: 435685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
    Baumgartner HR
    J Physiol; 1969 Apr; 201(2):409-23. PubMed ID: 5780550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.
    Born GV; Juengjaroen K; Michal F
    Br J Pharmacol; 1972 Jan; 44(1):117-39. PubMed ID: 5015032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of platelets and blood vessels--vascular injuries induced by platelet activation in vivo.
    Yamazaki H; Fujimoto T; Suzuki H; Akamatsu N; Katagiri Y; Yamaguchi A; Tanoue K
    Jpn Circ J; 1992 Feb; 56(2):178-86. PubMed ID: 1548839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-endorphin and met-enkephalin on platelet activity.
    Tirelli A; Guastafierro S; Annunziata S; Guariglia R; Coppola L
    Am J Hematol; 2001 Sep; 68(1):1-3. PubMed ID: 11559929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.